Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585455 · ClinicalTrials.gov registry record
Vascular Effects of Sertraline in Heart Failure
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 4
- Enrollment target
NCT00585455: Clinical Trial study, sponsored by Yale University.
NCT00585455 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585455 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
To determine the effects of chronic sertraline treatment on brachial artery flow-mediated dilation in patients with chronic heart failure and depression
Interventions
- DRUG sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-07 |
Why NCT00585455 stopped before completion
NCT00585455 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which sertraline is the first listed.
NCT00585455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00585455 about?
NCT00585455 is a clinical study titled "Vascular Effects of Sertraline in Heart Failure". To determine the effects of chronic sertraline treatment on brachial artery flow-mediated dilation in patients with chronic heart failure and depression
What is the current status of trial NCT00585455?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2006-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00585455?
The interventions under investigation include: sertraline (DRUG).
Who is sponsoring clinical trial NCT00585455?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia